Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
September 09, 2026
Not intended for U.S. and UK Media
U.S. FDA grants accelerated approval to Bayer’s targeted therapy sevabertinib as a first-line treatment option for adults with HER2-mutant non-small cell lung cancer
September 09, 2026
Bayer and Neste close commercial agreement to jointly scale newgold® winter canola for biofuels production
September 09, 2026
Not intended for U.S. and UK Media
Bayer initiates Phase II study of investigational GIRK4 inhibitor in patients with atrial fibrillation
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
